<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="and creation of adaptations, all for non-commercial purposes. Abstract During" exact="influenza" post="infection, hemagglutinins (HAs) on the viral surface bind to"/>
 <result pre="host cell’s surface. While all HAs bind sialic acids, human" exact="influenza" post="targets terminal α2,6 sialic acids and avian influenza targets"/>
 <result pre="sialic acids, human influenza targets terminal α2,6 sialic acids and" exact="avian influenza" post="targets α2,3 sialic acids. For interspecies transmission (zoonosis), HA"/>
 <result pre="acids, human influenza targets terminal α2,6 sialic acids and avian" exact="influenza" post="targets α2,3 sialic acids. For interspecies transmission (zoonosis), HA"/>
 <result pre="binding analyzed against a panel of HAs derived from pathogenic" exact="influenza" post="strains including low pathogenic avian strains. This showed significant"/>
 <result pre="disease and zoonosis transmission. Introduction Worldwide, annual epidemics of seasonal" exact="influenza" post="are estimated to result in 3–5 million cases of"/>
 <result pre="annually are associated with respiratory diseases from seasonal influenza.1 While" exact="influenza" post="A and B viruses cause seasonal epidemics, only A"/>
 <result pre="(NA)—for example, the H1N1 strain pandemic in 2009.2 During infection," exact="influenza" post="virus particles display trimeric HAs that bind to sialosides"/>
 <result pre="surface of their host cells to facilitate internalization. While all" exact="influenza" post="strains bind sialosides, human strains preferentially bind to terminal"/>
 <result pre="human strains preferentially bind to terminal α2,6 sialic acids, whereas" exact="avian influenza" post="viruses show preference for α2,3 sialic acids.3,4 Zoonosis (interspecies"/>
 <result pre="strains preferentially bind to terminal α2,6 sialic acids, whereas avian" exact="influenza" post="viruses show preference for α2,3 sialic acids.3,4 Zoonosis (interspecies"/>
 <result pre="HA, enabling a switch from α2,3 to α2,6. This allows" exact="avian influenza" post="to infect humans, and often occurs in porcine (pig)"/>
 <result pre="enabling a switch from α2,3 to α2,6. This allows avian" exact="influenza" post="to infect humans, and often occurs in porcine (pig)"/>
 <result pre="Humans can be infected with avian, porcine, and other zoonotic" exact="influenza" post="viruses including avian influenza subtypes; H5N1, H7N9, and H9N2"/>
 <result pre="infected with avian, porcine, and other zoonotic influenza viruses including" exact="avian influenza" post="subtypes; H5N1, H7N9, and H9N2 and swine flu virus"/>
 <result pre="with avian, porcine, and other zoonotic influenza viruses including avian" exact="influenza" post="subtypes; H5N1, H7N9, and H9N2 and swine flu virus"/>
 <result pre="N-acetyl) play a significant role in species-dependent binding9 and that" exact="influenza" post="can bind phosphorylated, non-sialylated glycans determined against an array"/>
 <result pre="Whitesides and co-workers synthesized sialic acid containing glycopolymeric inhibitors of" exact="influenza" post="virus X-31 via a poly(N-acrylyloxy succinimide) reactive scaffold. Using"/>
 <result pre="and 2,6-sialyllactose-functional glycopolymers that were able to recognize two different" exact="influenza" post="strains. They found that 2,6-sialyllactose-functional glycopolymers inhibited hemagglutination caused"/>
 <result pre="used for the discrimination of human (H3N2) and avian (H5N1)" exact="influenza" post="using PEGylated gold particles presenting trivalent α2,6 sialic acid"/>
 <result pre="a multivalent nanoparticle platform to dissect the binding trends of" exact="influenza" post="HAs toward multivalent sialic acid isomers. A library-oriented screen"/>
 <result pre="obtained through BEI resources, NIAID, NIH: H1 HA protein from" exact="influenza" post="virus, A/California/07/2009 (H1N1)pdm09, recombinant from baculovirus, NR-44074, H2 HA"/>
 <result pre="A/California/07/2009 (H1N1)pdm09, recombinant from baculovirus, NR-44074, H2 HA protein from" exact="influenza" post="virus, A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668, H3 HA"/>
 <result pre="A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668, H3 HA protein from" exact="influenza" post="virus, A/Uruguay/716/2007 (H3N2), recombinant from baculovirus, NR-15168, H4 HA"/>
 <result pre="A/Uruguay/716/2007 (H3N2), recombinant from baculovirus, NR-15168, H4 HA protein from" exact="influenza" post="virus, A/mallard/Alberta/455/2015 (H4N6), recombinant from baculovirus, NR-51128, H5 HA"/>
 <result pre="A/mallard/Alberta/455/2015 (H4N6), recombinant from baculovirus, NR-51128, H5 HA protein from" exact="influenza" post="virus, A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus, NR-43739, H7 HA"/>
 <result pre="A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus, NR-43739, H7 HA protein from" exact="influenza" post="virus, A/Canada/rv444/2004 (H7N3), recombinant from baculovirus, NR-43740, H9 HA"/>
 <result pre="A/Canada/rv444/2004 (H7N3), recombinant from baculovirus, NR-43740, H9 HA protein from" exact="influenza" post="virus, A/Hong Kong/33982/2009 (H9N2), recombinant from baculovirus, NR-41792 and"/>
 <result pre="NR-41792 and H10 HA protein with C-terminal histidine tag from" exact="influenza" post="virus, A/harbor seal/Germany/1/2014 (H10N7), recombinant from baculovirus, NR-50172. Clear"/>
 <result pre="investigated the mammalian transmissibility of many avian and other zoonotic" exact="influenza" post="strains including H7N9,49 H9N2,50 and H10N852 by looking at"/>
 <result pre="the affinity of sialic acid isomers against a panel of" exact="influenza" post="A HAs to map their affinity. This allows for"/>
 <result pre="were then interrogated for their binding against a panel of" exact="influenza" post="A HAs including three mammalian strains, four avian strains,"/>
 <result pre="including three mammalian strains, four avian strains, and a zoonotic" exact="influenza" post="strain. As expected, 2,3-sialyllactosamine had strong affinity toward avian"/>
 <result pre="obtained through BEI Resources, NIAID, NIH: H1 HA protein from" exact="influenza" post="virus, A/California/07/2009 (H1N1)pdm09, recombinant from baculovirus, NR-44074, H2 HA"/>
 <result pre="A/California/07/2009 (H1N1)pdm09, recombinant from baculovirus, NR-44074, H2 HA protein from" exact="influenza" post="virus, A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668, H3 HA"/>
 <result pre="A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668, H3 HA protein from" exact="influenza" post="virus, A/Uruguay/716/2007 (H3N2), recombinant from baculovirus, NR-15168, H4 HA"/>
 <result pre="A/Uruguay/716/2007 (H3N2), recombinant from baculovirus, NR-15168, H4 HA protein from" exact="influenza" post="virus, A/mallard/Alberta/455/2015 (H4N6), recombinant from baculovirus, NR-51128, H5 HA"/>
 <result pre="A/mallard/Alberta/455/2015 (H4N6), recombinant from baculovirus, NR-51128, H5 HA protein from" exact="influenza" post="virus, A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus, NR-43739, H7 HA"/>
 <result pre="A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus, NR-43739, H7 HA protein from" exact="influenza" post="virus, A/Canada/rv444/2004 (H7N3), recombinant from baculovirus, NR-43740, H9 HA"/>
 <result pre="A/Canada/rv444/2004 (H7N3), recombinant from baculovirus, NR-43740, H9 HA protein from" exact="influenza" post="virus, A/Hong Kong/33982/2009 (H9N2), recombinant from baculovirus, NR-41792 and"/>
 <result pre="NR-41792 and H10 HA protein with C-terminal histidine tag from" exact="influenza" post="virus, A/harbor seal/Germany/1/2014 (H10N7), recombinant from baculovirus, NR-50172. References"/>
</results>
